跳至主要内容
临床试验/NCT02399059
NCT02399059已完成3 期

Effect of Peritoneal Lavage With Clindamycin-Gentamicin Solution During Elective Colorectal Cancer Surgery on the Oncologic Outcome

Hospital General Universitario Elche0 个研究点目标入组 106 人开始时间: 2011年1月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
106
主要终点
Global survival

研究概览

简要总结

Antibiotic lavage reduces bacterial contamination and decreases SSI infection rate. SSI leads to an immunocompromised situation, leaving unattended the neoplasm. It has been described that SSI may result in a worse oncologic outcome.

详细描述

Antibiotics combined with lavage have demonstrated a reduction in the bacterial contamination and decreases SSI infection rate. SSI leads to an immunocompromised situation, as immunologic defense is focused on controlling the septic focus, leaving unattended the neoplasm. It has been described that SSI may result in a worse oncologic outcome. The aim of this study is to evaluate prospectively the effect of peritoneal lavage with clindamycin and gentamicin on the oncologic outcome of colorectal tumours.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • diagnosis of colon neoplasms
  • plans to undergo an elective surgery with curative aims

排除标准

  • preoperative diagnosis of chronic renal failure (because of the risk of nephrotoxicity associated with intraperitoneal gentamicin absorption)
  • allergy to gentamicin or clindamycin.

结局指标

主要结局

Global survival

时间窗: 36 months after intervention

次要结局

  • Disease free survival(36 months after intervention)

研究者

发起方
Hospital General Universitario Elche
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jaime Ruiz-Tovar, MD, PhD

MD, PhD

Hospital General Universitario Elche

相似试验